Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Needham analyst Ryan MacDonald has reiterated their bullish stance on COUR stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

However, high correlation to crude can be a double-edged sword, as many energy investors experienced when crude prices ...

The near term technicals are highly bullish as the chart, moving averages, and indicators show that the outlook is strong.

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

Esports revenue includes media rights, ticket sales, sponsorship and advertising deals, but the entire gaming industry ...

CDNS stock currently trades at around $234 and analysts hold a consensus price target of $253.34 for the stock with a Buy rating. Its software niche and innovation have helped Cadence maintain its ...

Investors might want to bet on Qualcomm (QCOM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...